Stock Price Prediction

HCM stock is currently trading at $15.56, reflecting a bullish sentiment due to its recent developments. The acceptance of its New Drug Application for a lung cancer therapy and the divestment of a non-core JV for $608M are expected to strengthen its focus on core R&D and boost financial flexibility. With these catalysts, the stock could test resistance levels near $14.90-$15.00, signaling potential upside momentum.

HCM stock currently trades at $15.56. Bears argue that despite recent positive developments like the priority review for its lung cancer therapy, the stock's valuation remains stretched given its limited profitability and high R&D expenses. Additionally, the divestment of its non-core JV may not significantly offset concerns about its cash burn and long-term growth sustainability.